Ten-year hemoglobin A1c trajectories and outcomes in Type 2 diabetes mellitus: The Diabetes & Aging Study

Abstract Aims To classify trajectories of long term HbA1c values in patients after diagnosis of Type 2 diabetes and examine each trajectory's associations with subsequent microvascular and macrovascular events and mortality. Methods Longitudinal follow-up of 28,016 patients newly diagnosed with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of diabetes and its complications 2017-01, Vol.31 (1), p.94-100
Hauptverfasser: Laiteerapong, Neda, Karter, Andrew J, Moffet, Howard H, Cooper, Jennifer M, Gibbons, Robert D, Liu, Jennifer Y, Gao, Yue, Huang, Elbert S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 100
container_issue 1
container_start_page 94
container_title Journal of diabetes and its complications
container_volume 31
creator Laiteerapong, Neda
Karter, Andrew J
Moffet, Howard H
Cooper, Jennifer M
Gibbons, Robert D
Liu, Jennifer Y
Gao, Yue
Huang, Elbert S
description Abstract Aims To classify trajectories of long term HbA1c values in patients after diagnosis of Type 2 diabetes and examine each trajectory's associations with subsequent microvascular and macrovascular events and mortality. Methods Longitudinal follow-up of 28,016 patients newly diagnosed with Type 2 diabetes. Latent growth mixture modeling to identify ten-year HbA1c trajectories. Cox proportional hazards models to assess how HbA1c trajectories were associated with events (microvascular and macrovascular) and mortality. Results We identified 5 HbA1c trajectories: “low stable” (82.5%), “moderate increasing late” (5.1%), “high decreasing early” (4.9%), “moderate peaking late” (4.1%) and “moderate peaking early” (3.3%). After adjusting for average HbA1c, compared to the low stable trajectory, all non-stable trajectories were associated with higher incidences of microvascular events (hazard ratio (HR) range, 1.28 (95% CI, 1.08–1.53) (high decreasing early) to 1.45 (95% CI, 1.20–1.75) (moderate peaking early). The high decreasing early trajectory was associated with an increased mortality risk (HR, 1.27 (95% CI, 1.03–1.58)). Trajectories were not associated with macrovascular events. Conclusions Non-stable HbA1c trajectories was associated with greater risk of microvascular events and mortality. These findings suggest a potential benefit of early diabetes detection, prioritizing good glycemic control, and maintaining control over time.
doi_str_mv 10.1016/j.jdiacomp.2016.07.023
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5209280</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1056872716303026</els_id><sourcerecordid>1859489052</sourcerecordid><originalsourceid>FETCH-LOGICAL-c587t-6525b7f12a62046dfa287273e3cc4fdf188ea49285bcc2843b17d286f841ab9a3</originalsourceid><addsrcrecordid>eNqNUk1v1DAQjRCIlsJfqCwhIS5ZxnbsOBwqVuVTqsShi8TNcpzJ1iGJFzuptP8eR9st0Auc7Bm_eTNvnrPsnMKKApVvulXXOGP9sFuxFK-gXAHjj7JTqkqeFxK-P053EDJXJStPsmcxdgAghaBPsxNWCuAFiNPMbXDM92gCucHBb3tfu5GsqSVTMB3ayQeHkZixIX6eUrsUJMBmv0PCSJqgximlBux7N83xLdncIHl_TL8i660bt-R6mpv98-xJa_qIL-7Os-zbxw-by8_51ddPXy7XV7kVqpxyKZioy5YyIxkUsmkNWxRw5NYWbdNSpdAUFVOitpapgte0bJiSrSqoqSvDz7KLA-9urgdsLI5JSq93wQ0m7LU3Tv_9MrobvfW3WjBItJAIXt8RBP9zxjjpwUWbFJoR_Rw1VaIqVAWC_QeUC8kryWiCvnwA7fwcxrSJhVBwqIpCJZQ8oGzwMQZs7-emoBfjdaePxuvFeA2lTsanwvM_Vd-XHZ1OgHcHAKbd3zoMOlqHo8XGheSzbrz7d4-LBxS2d6Ozpv-Be4y_9ejINOjr5fst3lHJgQOT_Bctj9aq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1855309448</pqid></control><display><type>article</type><title>Ten-year hemoglobin A1c trajectories and outcomes in Type 2 diabetes mellitus: The Diabetes &amp; Aging Study</title><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Laiteerapong, Neda ; Karter, Andrew J ; Moffet, Howard H ; Cooper, Jennifer M ; Gibbons, Robert D ; Liu, Jennifer Y ; Gao, Yue ; Huang, Elbert S</creator><creatorcontrib>Laiteerapong, Neda ; Karter, Andrew J ; Moffet, Howard H ; Cooper, Jennifer M ; Gibbons, Robert D ; Liu, Jennifer Y ; Gao, Yue ; Huang, Elbert S</creatorcontrib><description>Abstract Aims To classify trajectories of long term HbA1c values in patients after diagnosis of Type 2 diabetes and examine each trajectory's associations with subsequent microvascular and macrovascular events and mortality. Methods Longitudinal follow-up of 28,016 patients newly diagnosed with Type 2 diabetes. Latent growth mixture modeling to identify ten-year HbA1c trajectories. Cox proportional hazards models to assess how HbA1c trajectories were associated with events (microvascular and macrovascular) and mortality. Results We identified 5 HbA1c trajectories: “low stable” (82.5%), “moderate increasing late” (5.1%), “high decreasing early” (4.9%), “moderate peaking late” (4.1%) and “moderate peaking early” (3.3%). After adjusting for average HbA1c, compared to the low stable trajectory, all non-stable trajectories were associated with higher incidences of microvascular events (hazard ratio (HR) range, 1.28 (95% CI, 1.08–1.53) (high decreasing early) to 1.45 (95% CI, 1.20–1.75) (moderate peaking early). The high decreasing early trajectory was associated with an increased mortality risk (HR, 1.27 (95% CI, 1.03–1.58)). Trajectories were not associated with macrovascular events. Conclusions Non-stable HbA1c trajectories was associated with greater risk of microvascular events and mortality. These findings suggest a potential benefit of early diabetes detection, prioritizing good glycemic control, and maintaining control over time.</description><identifier>ISSN: 1056-8727</identifier><identifier>EISSN: 1873-460X</identifier><identifier>DOI: 10.1016/j.jdiacomp.2016.07.023</identifier><identifier>PMID: 27503405</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aging ; Blood pressure ; Diabetes ; Endocrinology &amp; Metabolism ; Epidemiology ; Glycemic control ; Health risk assessment ; Hemoglobin ; Hispanic people ; Hyperglycemia ; Laboratories ; Legacy effect ; Microvascular disease ; Mortality ; Patients ; Standard deviation ; Statistical analysis ; Studies</subject><ispartof>Journal of diabetes and its complications, 2017-01, Vol.31 (1), p.94-100</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Jan 01, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c587t-6525b7f12a62046dfa287273e3cc4fdf188ea49285bcc2843b17d286f841ab9a3</citedby><cites>FETCH-LOGICAL-c587t-6525b7f12a62046dfa287273e3cc4fdf188ea49285bcc2843b17d286f841ab9a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1855309448?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27503405$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Laiteerapong, Neda</creatorcontrib><creatorcontrib>Karter, Andrew J</creatorcontrib><creatorcontrib>Moffet, Howard H</creatorcontrib><creatorcontrib>Cooper, Jennifer M</creatorcontrib><creatorcontrib>Gibbons, Robert D</creatorcontrib><creatorcontrib>Liu, Jennifer Y</creatorcontrib><creatorcontrib>Gao, Yue</creatorcontrib><creatorcontrib>Huang, Elbert S</creatorcontrib><title>Ten-year hemoglobin A1c trajectories and outcomes in Type 2 diabetes mellitus: The Diabetes &amp; Aging Study</title><title>Journal of diabetes and its complications</title><addtitle>J Diabetes Complications</addtitle><description>Abstract Aims To classify trajectories of long term HbA1c values in patients after diagnosis of Type 2 diabetes and examine each trajectory's associations with subsequent microvascular and macrovascular events and mortality. Methods Longitudinal follow-up of 28,016 patients newly diagnosed with Type 2 diabetes. Latent growth mixture modeling to identify ten-year HbA1c trajectories. Cox proportional hazards models to assess how HbA1c trajectories were associated with events (microvascular and macrovascular) and mortality. Results We identified 5 HbA1c trajectories: “low stable” (82.5%), “moderate increasing late” (5.1%), “high decreasing early” (4.9%), “moderate peaking late” (4.1%) and “moderate peaking early” (3.3%). After adjusting for average HbA1c, compared to the low stable trajectory, all non-stable trajectories were associated with higher incidences of microvascular events (hazard ratio (HR) range, 1.28 (95% CI, 1.08–1.53) (high decreasing early) to 1.45 (95% CI, 1.20–1.75) (moderate peaking early). The high decreasing early trajectory was associated with an increased mortality risk (HR, 1.27 (95% CI, 1.03–1.58)). Trajectories were not associated with macrovascular events. Conclusions Non-stable HbA1c trajectories was associated with greater risk of microvascular events and mortality. These findings suggest a potential benefit of early diabetes detection, prioritizing good glycemic control, and maintaining control over time.</description><subject>Aging</subject><subject>Blood pressure</subject><subject>Diabetes</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Epidemiology</subject><subject>Glycemic control</subject><subject>Health risk assessment</subject><subject>Hemoglobin</subject><subject>Hispanic people</subject><subject>Hyperglycemia</subject><subject>Laboratories</subject><subject>Legacy effect</subject><subject>Microvascular disease</subject><subject>Mortality</subject><subject>Patients</subject><subject>Standard deviation</subject><subject>Statistical analysis</subject><subject>Studies</subject><issn>1056-8727</issn><issn>1873-460X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNUk1v1DAQjRCIlsJfqCwhIS5ZxnbsOBwqVuVTqsShi8TNcpzJ1iGJFzuptP8eR9st0Auc7Bm_eTNvnrPsnMKKApVvulXXOGP9sFuxFK-gXAHjj7JTqkqeFxK-P053EDJXJStPsmcxdgAghaBPsxNWCuAFiNPMbXDM92gCucHBb3tfu5GsqSVTMB3ayQeHkZixIX6eUrsUJMBmv0PCSJqgximlBux7N83xLdncIHl_TL8i660bt-R6mpv98-xJa_qIL-7Os-zbxw-by8_51ddPXy7XV7kVqpxyKZioy5YyIxkUsmkNWxRw5NYWbdNSpdAUFVOitpapgte0bJiSrSqoqSvDz7KLA-9urgdsLI5JSq93wQ0m7LU3Tv_9MrobvfW3WjBItJAIXt8RBP9zxjjpwUWbFJoR_Rw1VaIqVAWC_QeUC8kryWiCvnwA7fwcxrSJhVBwqIpCJZQ8oGzwMQZs7-emoBfjdaePxuvFeA2lTsanwvM_Vd-XHZ1OgHcHAKbd3zoMOlqHo8XGheSzbrz7d4-LBxS2d6Ozpv-Be4y_9ejINOjr5fst3lHJgQOT_Bctj9aq</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Laiteerapong, Neda</creator><creator>Karter, Andrew J</creator><creator>Moffet, Howard H</creator><creator>Cooper, Jennifer M</creator><creator>Gibbons, Robert D</creator><creator>Liu, Jennifer Y</creator><creator>Gao, Yue</creator><creator>Huang, Elbert S</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>Ten-year hemoglobin A1c trajectories and outcomes in Type 2 diabetes mellitus: The Diabetes &amp; Aging Study</title><author>Laiteerapong, Neda ; Karter, Andrew J ; Moffet, Howard H ; Cooper, Jennifer M ; Gibbons, Robert D ; Liu, Jennifer Y ; Gao, Yue ; Huang, Elbert S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c587t-6525b7f12a62046dfa287273e3cc4fdf188ea49285bcc2843b17d286f841ab9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aging</topic><topic>Blood pressure</topic><topic>Diabetes</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Epidemiology</topic><topic>Glycemic control</topic><topic>Health risk assessment</topic><topic>Hemoglobin</topic><topic>Hispanic people</topic><topic>Hyperglycemia</topic><topic>Laboratories</topic><topic>Legacy effect</topic><topic>Microvascular disease</topic><topic>Mortality</topic><topic>Patients</topic><topic>Standard deviation</topic><topic>Statistical analysis</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laiteerapong, Neda</creatorcontrib><creatorcontrib>Karter, Andrew J</creatorcontrib><creatorcontrib>Moffet, Howard H</creatorcontrib><creatorcontrib>Cooper, Jennifer M</creatorcontrib><creatorcontrib>Gibbons, Robert D</creatorcontrib><creatorcontrib>Liu, Jennifer Y</creatorcontrib><creatorcontrib>Gao, Yue</creatorcontrib><creatorcontrib>Huang, Elbert S</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of diabetes and its complications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laiteerapong, Neda</au><au>Karter, Andrew J</au><au>Moffet, Howard H</au><au>Cooper, Jennifer M</au><au>Gibbons, Robert D</au><au>Liu, Jennifer Y</au><au>Gao, Yue</au><au>Huang, Elbert S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ten-year hemoglobin A1c trajectories and outcomes in Type 2 diabetes mellitus: The Diabetes &amp; Aging Study</atitle><jtitle>Journal of diabetes and its complications</jtitle><addtitle>J Diabetes Complications</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>31</volume><issue>1</issue><spage>94</spage><epage>100</epage><pages>94-100</pages><issn>1056-8727</issn><eissn>1873-460X</eissn><abstract>Abstract Aims To classify trajectories of long term HbA1c values in patients after diagnosis of Type 2 diabetes and examine each trajectory's associations with subsequent microvascular and macrovascular events and mortality. Methods Longitudinal follow-up of 28,016 patients newly diagnosed with Type 2 diabetes. Latent growth mixture modeling to identify ten-year HbA1c trajectories. Cox proportional hazards models to assess how HbA1c trajectories were associated with events (microvascular and macrovascular) and mortality. Results We identified 5 HbA1c trajectories: “low stable” (82.5%), “moderate increasing late” (5.1%), “high decreasing early” (4.9%), “moderate peaking late” (4.1%) and “moderate peaking early” (3.3%). After adjusting for average HbA1c, compared to the low stable trajectory, all non-stable trajectories were associated with higher incidences of microvascular events (hazard ratio (HR) range, 1.28 (95% CI, 1.08–1.53) (high decreasing early) to 1.45 (95% CI, 1.20–1.75) (moderate peaking early). The high decreasing early trajectory was associated with an increased mortality risk (HR, 1.27 (95% CI, 1.03–1.58)). Trajectories were not associated with macrovascular events. Conclusions Non-stable HbA1c trajectories was associated with greater risk of microvascular events and mortality. These findings suggest a potential benefit of early diabetes detection, prioritizing good glycemic control, and maintaining control over time.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27503405</pmid><doi>10.1016/j.jdiacomp.2016.07.023</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1056-8727
ispartof Journal of diabetes and its complications, 2017-01, Vol.31 (1), p.94-100
issn 1056-8727
1873-460X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5209280
source ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland
subjects Aging
Blood pressure
Diabetes
Endocrinology & Metabolism
Epidemiology
Glycemic control
Health risk assessment
Hemoglobin
Hispanic people
Hyperglycemia
Laboratories
Legacy effect
Microvascular disease
Mortality
Patients
Standard deviation
Statistical analysis
Studies
title Ten-year hemoglobin A1c trajectories and outcomes in Type 2 diabetes mellitus: The Diabetes & Aging Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A39%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ten-year%20hemoglobin%20A1c%20trajectories%20and%20outcomes%20in%20Type%202%20diabetes%20mellitus:%20The%20Diabetes%20&%20Aging%20Study&rft.jtitle=Journal%20of%20diabetes%20and%20its%20complications&rft.au=Laiteerapong,%20Neda&rft.date=2017-01-01&rft.volume=31&rft.issue=1&rft.spage=94&rft.epage=100&rft.pages=94-100&rft.issn=1056-8727&rft.eissn=1873-460X&rft_id=info:doi/10.1016/j.jdiacomp.2016.07.023&rft_dat=%3Cproquest_pubme%3E1859489052%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1855309448&rft_id=info:pmid/27503405&rft_els_id=S1056872716303026&rfr_iscdi=true